טוען...
Health expenditure comparison of extended-release metoprolol succinate and immediate-release metoprolol tartarate
BACKGROUND: Metoprolol, a selective beta-1 blocker, is available in two different salt forms in the market – metoprolol succinate (MS) and metoprolol tartarate (MT). Both the formulations are Food and Drug Administration approved for the treatment of hypertension. Several studies have shown similar...
שמור ב:
| Main Authors: | , |
|---|---|
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
Dove Medical Press
2012
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3284258/ https://ncbi.nlm.nih.gov/pubmed/22359463 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/CEOR.S27609 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|